Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$696M |
| 2 |
Moderna
MRNA
|
+$487M |
| 3 |
Analog Devices
ADI
|
+$272M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$261M |
| 5 |
Tesla
TSLA
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$670M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$335M |
| 4 |
Alibaba
BABA
|
+$323M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.45% |
| 2 | Healthcare | 13.43% |
| 3 | Financials | 12.56% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Kodak
KODK
$974M
| $1.31M | ﹤0.01% |
192,716
+16,375
| +9% | +$120K |
|
3227
iShares Government/Credit Bond ETF
GBF
$128M
| $1.31M | ﹤0.01% |
10,751
+1
| +0% | +$123 |
|
|
TBHC
3228
DELISTED
The Brand House Collective
TBHC
| $1.31M | ﹤0.01% |
68,178
+25,102
| +58% | +$496K |
|
3229
Theravance Biopharma
TBPH
$879M
| $1.31M | ﹤0.01% |
176,421
+1,062
| +0.6% | +$11.9K |
|
3230
Pure Cycle
PCYO
$274M
| $1.3M | ﹤0.01% |
98,025
-1,147
| -1% | -$16.6K |
|
3231
Apyx Medical
APYX
$128M
| $1.3M | ﹤0.01% |
94,140
+7,770
| +9% | +$81.7K |
|
3232
Valhi
VHI
$458M
| $1.3M | ﹤0.01% |
55,595
+18
| +0% | +$423 |
|
3233
Rekor Systems
REKR
$96.8M
| $1.29M | ﹤0.01% |
112,779
+20,270
| +22% | +$184K |
|
3234
BioAtla
BCAB
$5.41M
| $1.29M | ﹤0.01% |
876
+257
| +42% | +$501K |
|
3235
Intrepid Potash
IPI
$493M
| $1.29M | ﹤0.01% |
41,732
+2,156
| +5% | +$67.5K |
|
|
IEA
3236
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $1.29M | ﹤0.01% |
112,758
+11,604
| +11% | +$142K |
|
3237
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$42.1B
| $1.28M | ﹤0.01% |
35,410
-6,700
| -16% | -$249K |
|
|
KALV
3238
DELISTED
KalVista Pharmaceuticals
KALV
| $1.28M | ﹤0.01% |
73,236
-12,444
| -15% | -$252K |
|
3239
argenx
ARGX
$52.5B
| $1.28M | ﹤0.01% |
4,229
+345
| +9% | +$109K |
|
|
ARD
3240
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $1.28M | ﹤0.01% |
50,110
+6,671
| +15% | +$167K |
|
3241
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
| $1.27M | ﹤0.01% |
21,668
+11,433
| +112% | +$700K |
|
|
RPT
3242
Rithm Property Trust
RPT
$105M
| $1.27M | ﹤0.01% |
15,721
+2,603
| +20% | +$209K |
|
|
NAGE
3243
Niagen Bioscience
NAGE
$240M
| $1.27M | ﹤0.01% |
202,963
+21,346
| +12% | +$176K |
|
3244
Spyre Therapeutics
SYRE
$8.94B
| $1.27M | ﹤0.01% |
6,380
+484
| +8% | +$84.6K |
|
3245
American Outdoor Brands
AOUT
$160M
| $1.27M | ﹤0.01% |
51,601
+4,577
| +10% | +$128K |
|
3246
Avita Medical
RCEL
$241M
| $1.27M | ﹤0.01% |
71,458
+11,024
| +18% | +$208K |
|
3247
Carter Bankshares
CARE
$760M
| $1.26M | ﹤0.01% |
88,907
+6,912
| +8% | +$85.4K |
|
|
GORV
3248
DELISTED
Lazydays
GORV
| $1.26M | ﹤0.01% |
1,972
+368
| +23% | +$247K |
|
|
NOAH
3249
Noah Holdings
NOAH
$588M
| $1.26M | ﹤0.01% |
33,928
-4,434
| -12% | -$176K |
|
|
EGIO
3250
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.26M | ﹤0.01% |
13,227
+869
| +7% | +$91.6K |
|
Similar funds
Bank of New York Mellon's Q3 2021 Portfolio in Review
As of Q3 2021, Bank of New York Mellon held 4,634 positions worth $512B, down 0.89% from $517B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of New York Mellon's Q3 2021 filing shows 243 new, 2,575 increased, 1,388 reduced and 114 closed positions. Its largest new stake was GXO Logistics: 863,863 shares worth $67.8M. The largest sale was Apple, an estimated $670M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2021 buy was GXO Logistics: 863,863 shares worth $67.8M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $696M increase.
- Bank of New York Mellon's biggest Q3 2021 reduction was Apple, cutting an estimated $670M.
- Bank of New York Mellon fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $335M.
- Bank of New York Mellon's ten largest holdings make up 20% of its $512B portfolio in Q3 2021.
- Bank of New York Mellon opened 243 new positions and closed 114 in Q3 2021.
- Bank of New York Mellon's portfolio value fell 0.89% quarter-over-quarter to $512B.
Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.